5Bin F a n , Xin L i , K a n Z e , et al. Expression of T -iiel3er17 cells and signal transducers in patients with psoriasisvulgaris of blood-heat syndrome and blood-stasis syndrome[J]. Chin J Integr M e d , 2014, 25(4) :63-68.
6Kouris A , Pistiki A , Katoulis A , et al. Proinflammatorycytokine responses in patients with psoriasis [J]. Eur C y tokineNetw,2015, 21(1):10-16.
7Kimiko Nakajima, T a k a h i K a n d a, Mikiro Takaishi, etal. Distinct roles of IL-23 and IL-17 in the development ofpsoriasis-like lesions in a mouse model [J]. J I m m u n o l ,2011,186(7) :4481-489.
8Spuls P I , Hooft L . Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis:a critical appraisal[J]. Br J Dermatol, 2012, 167(4) :710-715.
9Cai S Q , Che n L R , W a n g H J , et al. Effect of S T A T 3phosphorylation and p53 expression on h u m a n epidermalnon melanoma cutaneous tumors [J]. Zhejiang D a X u eX u e Bao Yi X u e B a n , 2004, 33(4) :331- 334.
10Sano S , Cha n K S , Carbajal S , et al. Stat3 links activatedkerati-nocytes and immunocytes required for developmentof psoriasis ina novel transgenic mouse model [J]. NatM e d , 2005, 11(1) :43-9.
